According to the research report titled ‘Europe Vascular Graft Market Forecast 2027 By End-use, By Application, By Raw Material, Research Report, Country Outlook, COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share’, available with Market Study Report, Europe vascular graft market is slated to record a strong compound annual growth rate through 2027, amassing USD 928 million valuation by the end of forecast duration.
 

Rising number of chronic diseases like diabetes and atherosclerosis is a major factor driving the Europe vascular graft market growth. As per a report by WHO, atherosclerosis, a severe artery condition in which fatty material gets deposited in the inner walls causing blockage, accounts for over 1.8 million new cases each year.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/4037687/
 

Further, technological advancements to better produce vascular grafts such as the ones manufactured using biomaterials, along with their highly non-invasive nature are enhancing the market outlook, claims the study.
 

For the record, vascular grafts are manufactured using polyester and collagen. Such grafts help reduce the chances of graft rejection or incompatibility. They have high tensile strength, greater blood compatibility and longer lifespan as compared to alternatives.
 

Considering application range, Europe vascular graft industry is segmented into peripheral vascular repair, endovascular aneurysm repair, and hemodialysis access. Among these, endovascular aneurysm repair segment accounted for USD 260 million in 2020, and is anticipated to expand lucratively in the upcoming years as the procedure is highly non-invasive which is considerably useful in treating abdominal aortic aneurysm. In addition, it is cost-effective and involves shorter hospitalization time.
 

Speaking of raw material type, the marketplace is categorized into EPTFE grafts, polyester grafts, biosynthetic grafts, and polyurethane grafts. As cited in the report, polyester graft segment is expected to grow at 6.1% CAGR through 2027 owing to the technological advancements in raw materials over the past few years.
 

Moving on to end user spectrum, the business space is divided into ambulatory surgical centers, hospitals, and others. Among these, the hospital segment held 62.1% market share in 2020 and is likely to showcase strong growth trends in the upcoming years as hospitals provide many treatment options in cardiothoracic and hemodialysis procedures to patients who are suffering from chronic diseases.
 

Considering regional outlook, the U.K. market contributed USD 151.6 million to Europe vascular graft industry value in 2020 and is poised to record a CAGR of 6.9% by 2027, owing to the rising geriatric population in the country. In fact, the WHO claims that over 5.5 million people aged 65 and above reside in U.K., indicated a high demand for vascular grafts as they are at elevated risks of suffering from chronic ailments.
 

Prominent players influencing the industry trends are CryoLife Inc., Endologix Inc., W. L. Gore & Associates Inc., Terumo Corporation, Medtronic plc, LeMaitre Vascular Inc., Getinge AB, Cook Medical Inc., B. Braun Melsungen AG, and Becton, Dickinson and Company.